Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
Rasmus Juul KildemoesChristian HollensenBeverly M K BillerGudmundur JohannssonYutaka TakahashiMichael Højby RasmussenPublished in: European journal of endocrinology (2022)
This study extends the knowledge of the somapacitan dose-IGF-I response and provides information on clinical dosing of once-weekly somapacitan in patients with AGHD.